ecancer blogger Dr Gyawali gives his scientific highlights from ESMO 2016, covering the likely impact of the research.
For more on nivolumab for head and neck, you can read more through ecancer news.
For more from Dr Gyawali, read his regular blog with ecancer here.
ecancer's filming at ESMO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.